Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,441 | Dovepress* | 9,822+ | 1,635 | 11,457 | |
PubMed Central* | 1,619 | 437 | 2,056 | ||
Totals | 11,441 | 2,072 | 13,513 | ||
*Since 8 June 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar